Jadhav, Satyawan B.
Amore, Benny M. http://orcid.org/0000-0001-5870-5378
Bockbrader, Howard
Crass, Ryan L. http://orcid.org/0000-0001-5403-4730
Chapel, Sunny
Sasiela, William J.
Emery, Maurice G. http://orcid.org/0000-0002-2985-6174
Funding for this research was provided by:
Esperion Therapeutics, Inc.
Article History
Received: 22 December 2022
Accepted: 1 May 2023
First Online: 27 May 2023
Declarations
:
: SB Jadhav, RL Crass, H Bockbrader, and S Chapel were employees of Ann Arbor Pharmacometrics Group when this work was completed. H Bockbrader is a current employee of Amador Bioscience, formerly Ann Arbor Pharmacometrics Group. BM Amore is a current employee of Esperion Therapeutics, Inc. and may own stock and/or stock options. WJ Sasiela and MG Emery are current consultants for and former employees of Esperion Therapeutics, Inc. and may own stock and/or stock options.
: All the studies included in this model were conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines and were approved by an institutional review board or independent ethics committee at the study sites. All patients provided written informed consent.